Sundance Strategies, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Sundance Strategies, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | $204.5K | Jul 16, 2012 |
| FY2010 | Mar 31, 2011 | $204.5K | Jun 28, 2011 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | $159.1K | Jul 16, 2012 |
| FY2010 | Mar 31, 2011 | $159.1K | Jun 28, 2011 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($1.60M) | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | ($1.83M) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | ($2.81M) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | ($2.77M) | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | ($1.53M) | Jun 29, 2022 |
| FY2021 | Mar 31, 2020 | ($1.11M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | ($2.06M) | Aug 11, 2020 |
| FY2019 | Mar 31, 2018 | ($26.42M) | Jan 16, 2020 |
| FY2018 | Mar 31, 2017 | $2.01M | Oct 16, 2019 |
| FY2016 | Mar 31, 2016 | $495.1K | Jun 14, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($604.2K) | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | ($531.4K) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | ($682.3K) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | ($690.7K) | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | ($908.0K) | Jun 29, 2022 |
| FY2021 | Mar 31, 2020 | ($828.4K) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | ($1.09M) | Aug 11, 2020 |
| FY2019 | Mar 31, 2018 | ($3.51M) | Jan 16, 2020 |
| FY2018 | Mar 31, 2017 | $3.26M | Oct 16, 2019 |
| FY2016 | Mar 31, 2016 | $577.5K | Jun 14, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($916.2K) | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | ($666.6K) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | ($459.7K) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | ($813.2K) | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | ($818.4K) | Jun 29, 2022 |
| FY2021 | Mar 31, 2020 | ($750.3K) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | ($1.78M) | Aug 11, 2020 |
| FY2019 | Mar 31, 2018 | $6.02M | Jan 16, 2020 |
| FY2018 | Mar 31, 2017 | ($564.9K) | Oct 16, 2019 |
| FY2017 | Mar 31, 2016 | ($3.02M) | Apr 12, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $178.2K | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $338.9K | Jun 30, 2025 |
| FY2018 | Mar 31, 2018 | $941.6K | Oct 16, 2019 |
| FY2018 | Mar 31, 2017 | $34.17M | Oct 16, 2019 |
| FY2017 | Mar 31, 2016 | $29.85M | Apr 12, 2018 |
| FY2016 | Mar 31, 2015 | $26.71M | Jun 14, 2016 |
| FY2015 | Mar 31, 2014 | $17.08M | Jun 15, 2015 |
| FY2014 | Mar 31, 2013 | $6.84M | Jul 21, 2014 |
| FY2011 | Mar 31, 2012 | $247 | Jul 16, 2012 |
| FY2011 | Mar 31, 2011 | $878 | Jul 16, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $6.48M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $6.28M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $6.04M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $5.30M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $4.75M | Jun 29, 2022 |
| FY2021 | Mar 31, 2020 | $3.76M | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $2.62M | Aug 11, 2020 |
| FY2019 | Mar 31, 2018 | $1.14M | Jan 16, 2020 |
| FY2018 | Mar 31, 2017 | $7.94M | Oct 16, 2019 |
| FY2017 | Mar 31, 2016 | $5.81M | Apr 12, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($6.30M) | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | ($5.94M) | Jun 30, 2025 |
| FY2025 | Mar 31, 2023 | ($6.03M) | Jun 30, 2025 |
| FY2024 | Mar 31, 2022 | ($5.03M) | Jul 1, 2024 |
| FY2023 | Mar 31, 2021 | ($4.72M) | Jun 29, 2023 |
| FY2022 | Mar 31, 2020 | ($3.73M) | Jun 29, 2022 |
| FY2021 | Mar 31, 2019 | ($2.61M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2018 | ($195.1K) | Aug 11, 2020 |
| FY2019 | Mar 31, 2017 | $26.23M | Jan 16, 2020 |
| FY2018 | Mar 31, 2016 | $24.03M | Oct 16, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($38.50M) | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | ($36.90M) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | ($35.06M) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | ($32.25M) | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | ($29.48M) | Jun 29, 2022 |
| FY2021 | Mar 31, 2020 | ($27.96M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | ($26.84M) | Aug 11, 2020 |
| FY2019 | Mar 31, 2018 | ($24.79M) | Jan 16, 2020 |
| FY2018 | Mar 31, 2017 | $1.64M | Oct 16, 2019 |
| FY2017 | Mar 31, 2016 | ($373.8K) | Apr 12, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $168.6K | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $329.9K | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $553 | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $268.0K | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $21.2K | Jun 29, 2022 |
| FY2021 | Mar 31, 2020 | $28.8K | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $579 | Aug 11, 2020 |
| FY2019 | Mar 31, 2018 | $936.9K | Jan 16, 2020 |
| FY2018 | Mar 31, 2017 | $4.4K | Oct 16, 2019 |
| FY2017 | Mar 31, 2016 | $24.7K | Apr 12, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | 0 | Jun 29, 2022 |
| FY2018 | Mar 31, 2018 | 0 | Oct 16, 2019 |
| FY2018 | Mar 31, 2017 | 0 | Oct 16, 2019 |
| FY2016 | Mar 31, 2016 | 0 | Jun 14, 2016 |
| FY2016 | Dec 31, 2015 | 0 | Jun 14, 2016 |
| FY2016 | Sep 30, 2015 | 0 | Jun 14, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Jul 1, 2024 |
| FY2018 | Mar 31, 2018 | 0 | Oct 16, 2019 |
| FY2018 | Mar 31, 2017 | 0 | Oct 16, 2019 |
| FY2016 | Mar 31, 2016 | 0 | Jun 14, 2016 |
| FY2016 | Dec 31, 2015 | 0 | Jun 14, 2016 |
| FY2016 | Sep 30, 2015 | 0 | Jun 14, 2016 |
| FY2016 | Jun 30, 2015 | 0 | Jun 14, 2016 |
| FY2016 | Mar 31, 2015 | 0 | Jun 14, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 43.06M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | 42.26M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | 41.41M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | 41.41M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | 40.11M | Jun 29, 2022 |
| FY2021 | Mar 31, 2020 | 37.83M | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | 37.83M | Aug 11, 2020 |
| FY2019 | Mar 31, 2018 | 44.13M | Jan 16, 2020 |
| FY2018 | Mar 31, 2017 | 44.13M | Oct 16, 2019 |
| FY2017 | Mar 31, 2016 | 44.13M | Apr 12, 2018 |